Beyond the monoamine hypothesis: mechanisms, molecules and methods
- PMID: 15177084
- DOI: 10.1016/s0924-9338(02)00653-3
Beyond the monoamine hypothesis: mechanisms, molecules and methods
Abstract
The first effective antidepressants (monoamine oxidase inhibitors and tricyclic antidepressants) relied on their ability to augment serotonin and noradrenaline levels at the synapse. Forty years later, the same biological model led to the supremacy of the serotonergic hypothesis to explain not only the pathophysiology of depressive illness, but also the neuropharmacological basis for obsessive compulsive disorder, phobias, posttraumatic stress disorder, and even generalized anxiety disorder. It could be argued that the blinkered view of depression as a solely serotonergic phenomenon has not only restrained and limited research into other potential systems, but has also slowed down the discovery of putative antidepressant drugs. While some might argue that the hypothalamic-pituitary-adrenal (HPA) axis explains an individual's sensitivity to depression, there are others who equally claim that the most likely explanations are to be found in the neuropsychopharmacology of the immune system or even through reductions in hippocampal volume. There is a richness of possibilities regarding the mechanisms for antidepressant activity embracing theoretical, pharmacological and clinical data. However, the methods by which putative antidepressants are assessed and their clinical efficacy demonstrated are not always robust. That current clinical comparisons of antidepressants rarely show major differences in efficacy between existing molecules could be taken as an indication that "all drugs are the same" or perhaps, more insightfully, as an indication that the ubiquitous Hamilton depression (HAM-D) rating scales are not sensitive to inter-drug differences, even though pronounced pharmacodynamic differences between molecules are easily demonstrated. Any advances in the development of new antidepressants will have to find not only original compounds but also unique psychometric tests by which the drugs can be assessed in a sensitive, reliable, and valid manner.
Similar articles
-
Monoamine neurocircuitry in depression and strategies for new treatments.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:54-63. doi: 10.1016/j.pnpbp.2013.04.009. Epub 2013 Apr 19. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23602950 Review.
-
Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.Neuropsychopharmacology. 2006 Dec;31(12):2591-9. doi: 10.1038/sj.npp.1301092. Epub 2006 May 10. Neuropsychopharmacology. 2006. PMID: 16710317
-
Neural basis of major depressive disorder: Beyond monoamine hypothesis.Psychiatry Clin Neurosci. 2018 Jan;72(1):3-12. doi: 10.1111/pcn.12604. Epub 2017 Oct 19. Psychiatry Clin Neurosci. 2018. PMID: 28926161 Review.
-
Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.J Affect Disord. 2007 Dec;104(1-3):83-90. doi: 10.1016/j.jad.2007.02.017. Epub 2007 Apr 30. J Affect Disord. 2007. PMID: 17467808
-
Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB.Brain Res. 2006 Nov 29;1122(1):56-64. doi: 10.1016/j.brainres.2006.09.009. Epub 2006 Oct 3. Brain Res. 2006. PMID: 17022948
Cited by
-
Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine.Front Oncol. 2022 Sep 16;12:956923. doi: 10.3389/fonc.2022.956923. eCollection 2022. Front Oncol. 2022. PMID: 36185233 Free PMC article. Review.
-
Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.Cell Signal. 2005 May;17(5):549-57. doi: 10.1016/j.cellsig.2004.12.007. Cell Signal. 2005. PMID: 15683730 Free PMC article. Review.
-
Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods.Front Neurosci. 2015 Feb 20;9:37. doi: 10.3389/fnins.2015.00037. eCollection 2015. Front Neurosci. 2015. PMID: 25750611 Free PMC article. Review.
-
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?Int J Mol Sci. 2023 Jul 6;24(13):11142. doi: 10.3390/ijms241311142. Int J Mol Sci. 2023. PMID: 37446323 Free PMC article.
-
Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis.Mol Psychiatry. 2025 Feb;30(2):736-751. doi: 10.1038/s41380-024-02780-6. Epub 2024 Oct 15. Mol Psychiatry. 2025. PMID: 39406999 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources